Design of Small Molecule Therapeutics for the Treatment of Alzheimer Disease Based on the Discovery of Innovative Drug Targets


This web side is intended to facilitate communication amongst the project partners and to inform colleagues and the general public about the results of the project.


Pre-AD/PD Symposium
Prague Congress Centre
March 10, 2009


presentations available


For any further queries please contact:

Project Coordinator: Dr. Georg C. Terstappen, Sienabiotech S.p.A.
Project starting date: June 1, 2005  
Duration of the Project: 5 Years  
Partners of the Project: 8 (from 6 different countries)  


Disclaimer: The contents of the ADIT web side are the sole responsibility of the project coordinator and do not necessarily represent the opinion of the European Community.

PRIORITY LSH-2003-1.2.1-3 Novel therapeutic substances for neurodegenerative diseases in CNS and PNS.





  • cheap christian louboutin shoes
  • air max 90
  • cheap jerseys
  • ghd